Latest filing published 10 Feb 2026 for DNA X, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Clayton Crolius: trading record in brief
All filings by Clayton Crolius on record concern DNA X, Inc. In total, 4 filings cover trades dated from 15 September 2023 to 9 February 2026.
On the open market, the record shows 1 purchase worth €56k and 1 sale worth €15k. On balance, insiders were net buyers of €41k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants.
The latest filing, published on 10 February 2026, reports a share grant in DNA X, Inc. The clock since the last published purchase (18 September 2023) now reads 1,147 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Clayton Crolius
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,000 shares0Common StockSEC:0001493152-26-006055:0
- 11,634 shares@ US$1.4521.1% of flowCommon StockSEC:0001641172-25-006117:0
- 33,922 shares0Common StockSEC:0001493152-25-005765:0
- 86,700 shares@ US$0.68378.9% of flowCommon StockSEC:0001493152-23-032976:0Canonical exit: 14 Dec 2023 (T+90)
4 of 4 declarations